Formation of F2-isoprostanes during the oxidation of human low density lipoprotein by peroxynitrite.
Moore
K P
KP
Department of Clinical Pharmacology, Royal Postgraduate Medical School, London, UK.
Darley-Usmar
V
V
Morrow
J
J
Roberts
L J
LJ
D001095:Arachidonic Acids / Q000378:metabolism*; D015237:Dinoprost / Q000031:analogs & derivatives* / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D008077:Lipoproteins, LDL / Q000097:blood / Q000737:chemistry / Q000187:drug effects*; D008981:Molsidomine / Q000031:analogs & derivatives / Q000494:pharmacology; D009566:Nitrates / Q000494:pharmacology*; D010084:Oxidation-Reduction; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology
D001095:Arachidonic Acids; D008077:Lipoproteins, LDL; D009566:Nitrates; D010975:Platelet Aggregation Inhibitors; C039642:peroxynitric acid; C075750:8-epi-prostaglandin F2alpha; C002385:linsidomine; D015237:Dinoprost; D008981:Molsidomine